Risk of bias assessments for version 5 of the Cochrane review 'Convalescent plasma for people with COVID-19'
Claire Iannizzi(University of Cologne), Nicole Skoetz(Medical University of Vienna), Khai Li Chai(Monash University), Catherine Kimber(NHS Blood and Transplant), Lise J Estcourt(NHS Blood and Transplant), Cynthia So‐Osman(Sanquin), Ina Monsef(University of Cologne), Abigail Lamikanra(NHS Blood and Transplant), Erica M. Wood(Monash Health), Aikaj Jindal(Satguru Partap Singh Hospital), Sarah J Valk(Leiden University Medical Center), Nina Kreuzberger(University of Cologne), Nora Cryns(University of Cologne), Zoe McQuilten, Vanessa Piechotta(Robert Koch Institute), David J. Roberts(NHS Blood and Transplant)
Cited by 0
Related Papers
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.3k
SARS-CoV-2 evolution during treatment of chronic infection
|Nature|2021|1.1k
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
|JAMA|2020|884
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression
|The Lancet Infectious Diseases|2023|658
Patient Blood Management
|JAMA|2019|619